When should we use parenteral methotrexate?

Author： Mainman Hayley   McClaren Emma   Heycock Carol   Saravanan Vadivelu   Hamilton Jennifer   Kelly Clive  

Publisher： Springer Publishing Company

ISSN： 0770-3198

Source： Clinical Rheumatology, Vol.29, Iss.10, 2010-10, pp. : 1093-1098

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Should we adjust for gestational age when analysing birth weights? The use of z -scores revisited

By Delbaere Ilse   Vansteelandt Stijn   De Bacquer Dirk   Verstraelen Hans   Gerris Jan   De Sutter Petra   Temmerman Marleen  

Human Reproduction, Vol. 22, Iss. 8, 2007-08 ,pp. : 2080-2083

Oxford University Press

Access to resources Recommend Favorite

Granulocyte colony-stimulating factor for ischemic heart failure: should we use it?

By Baldo Marcelo   Rodrigues Sérgio   Mill José  

Heart Failure Reviews, Vol. 15, Iss. 6, 2010-11 ,pp. : 613-623

Springer Publishing Company

Access to resources Recommend Favorite

When and How Should We Cover Patients for Community-Acquired Methicillin-Resistant Staphylococcus aureus (MRSA) Pneumonia?

By  

Current Respiratory Medicine Reviews, Vol. 7, Iss. 4, 2011-08 ,pp. : 268-273

Bentham Science Publishers

Access to resources Recommend Favorite

The Use of Methotrexate in Respiratory Diseases

By  

Current Respiratory Medicine Reviews, Vol. 9, Iss. 5, 2013-10 ,pp. : 305-314

Bentham Science Publishers

Access to resources Recommend Favorite

Should we treat prehypertension?

By Kjeldsen Sverre E.   Oparil Suzanne   Narkiewicz Krzysztof   Hedner Thomas  

Blood Pressure, Vol. 18, Iss. 6, 2009-12 ,pp. : 298-299

Informa Healthcare

Access to resources Recommend Favorite